Thiazide diuretics have been first-line treatment for hypertension for over 30 years and their efficacy has been reinforced by recent trials, especially in elderly patients (Table 1) [1, 2] . However, almost from the time of their introduction there has been concern about their metabolic effects, including hypokalaemia and other electrolyte disturbances. More controversially, most but not all reports indicated that the thiazides may impair glucose tolerance in non-diabetic subjects [3] and can aggravate diabetes mellitus, particularly in non-insulin-dependent (NIDDM) patients [4] . This is generally regarded as a dose-related adverse effect [5, 6] but there is also a temporal component which has emerged during long-term followup of thiazide-treated patients [7] . The glucose intolerance is usually reversible after discontinuation of treatment [6, 8] , though this may take 6 months or more. It has been suggested that this 'wrong direction' side-effect of thiazides could be one of the reasons of the relatively modest -but still significantprotective effect towards ischaemic heart disease [9] , although there is no direct evidence for this view.
Although glucose intolerance may develop in about 3 % of hypertensive patients treated with thiazide diuretics [6, 8] the mechanism underlying this side effect has only been sparsely studied and remains largely unknown. Several potential mechanisms have been proposed. These can be grouped under two headings: 9 inhibition of insulin secretion by the beta cell, either directly or secondary to hypokalaemia [4, 10] 9 reduction in peripheral sensitivity to insulin, again either as a direct effect or as a consequence of hypokalaemia and hypomagnesaemia [11] [12] [13] . It has also been suggested that hypokalaemia is an aggravating factor rather than a primary stimulus in diuretic-associated hyperglycaemia [14] .
From the literature we have noted a striking similarity of action on pancreatic beta cells and the vascular system of drugs that modulate potassium channels. On the basis of these reports and of our own experiments on the vascular effects of hydrochlorothiazide and related compounds, we propose a novel hypothesis regarding the mechanism of the diabetogenic effects of thiazides.
In the pancreas, depolarization of the plasma membrane by closure of potassium channels and opening of cation and chloride channels leads to a opening of voltage dependent calcium channels and influx of calcium [15] [16] [17] . The resultant increase of intracellular calcium is crucial to the process of insulin release. Diazoxide, a drug structurally related to the thiazides, hyperpolarizes pancreatic beta cells by opening a specific class of ATP-dependent potassium (KATP) channels and the consequent hyperpolarization impairs [18] [19] [20] . For this reason diazoxide is used in the management of hypoglycaemia due to insulinoma. It is believed that the potassium channelopening properties of diazoxide are also responsible for its vasorelaxant activity in vitro and in vivo [21, 22] . Both pancreatic and vascular effects of diazoxide can be inhibited by sulphonylurea derivatives such as glibenclamide [19, 20, 23] , which are used in NIDDM [24, 25] . Sulphonylureas close KAT P channels resulting in depolarization of the beta-cell membrane, thereby promoting an influx of calcium via the opening of voltage-dependent calcium channels [19, 20] . Other openers of the KAT P channel, such as nicorandil and pinacidil, also inhibit insulin secretion [26, 27] , although at concentrations much higher than required for smooth muscle cell relaxation. In fact, during clinical use nicorandil does not significantly affect the plasma glucose level [28] . By contrast, conventional thiazides do not interact with this type of potassium channel.
Calcium-activated potassium channels
Like the KAT p channel, the large-conductance calcium-activated potassium (Kca) channel is also expressed in both pancreatic beta cells [25] and vascular smooth muscle cells [26] . In the beta cell of the rat the Kc~ channel can be blocked by quinine [25] , although it must be stressed that quinine is not selective for these channels. In humans, treatment with quinine is associated with hypoglycaemia due to stimulation of insulin release [27] , presumably due at least in part to inhibition of Kca channnels. Quinine is also known to cause inner ear disturbances including tinnitus, hearing loss, and vertigo and this is thought to be due at least in part to vasoconstriction [28] and consequent ischaemia [29] . Such a hypothesis is consistent with the increasingly recognized role of Kca channels in the regulation of vascular tone [30] .
It has recently been reported that hydrochlorothiazide at low concentrations (0.1-1.0 ~tmol/1) reduces insulin release in vitro. This was associated with a fall in glucose-stimulated 45Ca2 + uptake in beta cells [31] . As discussed above influx of calcium is one of the most distal steps in stimulus-secretion coupling in pancreatic beta cells and is crucial to insulin release [16] . As we will describe in the following section, the action of hydrochlorothiazide on calcium influx into the pancreatic beta cell shows a striking similarity with its effect on calcium entry into vascular smooth muscle cells.
New experimental data
The mechanism of the antihypertensive effect of the thiazides remains controversial. There is general agreement that there is a reduction in plasma volume during the first 1 or 2 weeks of thiazide therapy, which is usually commensurate with the fall in blood pressure. However, with continued treatment the plasma volume tends to return to normal while the blood pressure reduction is maintained, implying that peripheral resistance must be diminished. Several reports have supported this hypothesis by more direct estimation of the peripheral resistance [32] . The mechanism of the vascular effect is not understood.
Our group has been among the very few to study the acute vascular effects of the thiazides. In experiments with isolated guinea-pig arteries and vessels from human subcutaneous fat we have found that hydrochlorothiazide relaxes vascular smooth muscle cells in clinically relevant concentrations [33] through inhibition of calcium influx [34] . This effect of hydrochlorothiazide is associated with an increase in 86Rb § effiux, a marker of K + efflux, [35] indicating that hydrochlorothiazide increases membrane permeability to K + ions, probably by opening K + channels. The effects of hydrochlorothiazide on vascular tone, [Ca 2 + ]i and 86Rb+ efflux were inhibited by charybdotoxin and iberiotoxin, both relatively selective blockers of Kca channels [33, 34] . By contrast the KAT P channel blocker glibenclamide, and apamin, a blocker of small conductance Kca channels, did not affect hydrochlorothiazide-induced vasorelaxation or 86Rb+ effiux [35] . This is consistent with a previous report showing that hydrochlorothiazide does not affect the opening of single KAy P channels in the beta-cell plasma membrane [36] . These data suggest that the opening of Kca channels rather than KAT P channels mediates acute effects of thiazides on vascular smooth muscle cells. Interestingly electrophysiological studies have shown that cicletanine, a thiazide-like drug containing a furopyridine group, causes membrane hyperpolarisation in isolated canine femoral arteries [37] probably by an action on Kca channels. Since these channels are present in pancreatic beta cells [25] and by analogy with the potassium channel opening properties of diazoxide it is very likely that the effect of hydrochlorothiazide on Kca channels would be to hyperpolarise the beta-cell membrane, leading to reduced insulin release. This effect could explain the inhibitory action of hydrochlorothiazide on insulin secretion.
At present it is unclear how thiazides act on Kcachannels. It is possible that they interact directly with the Kca channel, but an indirect effect on the channel via an intracellular signalling mechanism is also possible. Ongoing studies in our department suggest that the K + channel opening properties of hydrochlorothiazide may depend on changes in intracellular pH (pHi). Effects of hydrochlorothiazide on pH i appear, in turn, to be associated with the ability of the drug to inhibit carbonic anhydrase activity [38] . Others have shown that pre-treatment with acetazolamide, an inhibitor of carbonic anhydrase, caused glucose intolerance in mice and reduced secretion of insulin in isolated pancreatic islets [39] , Fig. 1 . Representation of hypothesis. Activation of ATP-sensitive potassium channels (KAT P ) or of large-amplitude calciumactivated potassium channels (Kca) increase potassium conductance and hyperpolarise the cell membrane in the pancreatic beta cells, thereby reducing calcium entry through voltage-operated calcium channels (VOC) and so inhibiting insulin secretion although no human data is available for this drug. However, it should be emphasised that direct evidence concerning the role of carbonic anhydrase inhibiting activity is lacking, though we have found the vasorelaxant action of bendroflumethiazide, a very weak inhibitor of carbonic anhydrase [38] , to be much smaller than that of acetazolamide and hydrochlorothiazide and this action was not inhibited by charybdotoxin. This suggests that bendroflumethiazide does not act on Kca channels.
Summary and hypothesis
We can therefore summarise the following experimental findings, partly from our own studies and partly from the work of other groups: 9 calcium influx is an essential component in stimulus-secretion coupling in pancreatic beta-cells and excitation-contraction coupling in vascular smooth muscle cells 9 thiazides inhibit calcium influx in these cells 9 thiazides (e. g. 10 Ixmol/1 hydrochlorothiazide) also inhibit calcium entry in small mesenteric arteries 9 in vascular smooth muscle thiazides increase potassium permeability p r o b a b l y via large conductance Kca channels, resulting in m e m b r a n e hyperpolarisation and the closure of voltage-operated calcium channels.
We therefore propose the hypothesis illustrated in Figure 1 as an explanation for at least part of the adverse effect of thiazides on glucose homeostasis: in the absence of direct experimental evidence it omits mention of the possible role of carbonic anhydrase inhibition. In summary: 1. Thiazide diuretics directly or indirectly open the large-conductance Kca channel in the plasma membrane of the pancreatic beta cell.
2. This increases potassium permeability and causes hyperpolarisation of the m e m b r a n e , inhibiting calcium influx through voltage-operated calcium channels. 3. The reduction in intracellular calcium attenuates insulin release by the beta cell.
We do not know if the interaction with this class of ion channels is a significant mechanism for the chronic antihypertensive effects of the thiazides and we are not making any such proposal in our hypothesis. Our in vitro studies relate to acute responses to relatively high drug concentrations and may be of limited relevance for drugs which take weeks to achieve their maximal blood pressure-lowering effects. On the other hand it is known for the thiazide-like drug indapamide that during chronic treatment accumulation of the drug in the vascular smooth muscle cell takes place to levels 9 times greater than the plasma concentration [40] .
It is entirely possible that other, peripheral, diabetogenic actions of thiazides may be important. H o wever, we believe that ours is a plausible hypothesis. It raises the possibility that thiazides or thiazide-like drugs can be developed with few if any metabolic side-effects. Indapamide is structurally related to the thiazides but does not interact with Kca and KAT e channels [33] and has less effect on glucose, lipid and uric acid homeostasis [41] . Its exact m o d e of action remains uncertain, though it m a y act partly through blockade of voltage-operated calcium channels [33, 42] .
It should be noted that attempts have been made to synthesise compounds specificially intended to interact with Kca channels, but to date these are neither potent nor selective [43] .
